Product Design, Manufacturing & Innovation Resources

최신 출판물 – 장수 과학 관련 특허

Longevity Science

팁: 아래 선택 항목 외에도, 저희가 제공하는 두 개의 전체 데이터베이스를 검색하고 필터링할 수 있습니다.

> 무료 간행물 검색 도구 < 저자, 주제, 키워드, 날짜 또는 저널별로 검색.

> 무료 특허 검색 도구 < 유럽 ​​특허청의 영문 특허를 참조하십시오.

Longevity science
장수 과학의 발전은 노화의 생물학적 메커니즘을 겨냥한 혁신적인 개입을 통해 건강 수명과 기대 수명을 향상시키는 것을 목표로 합니다.

장수과학은 세포 노화, 텔로미어 역학, 후성유전적 변화, 미토콘드리아 기능 및 전신 염증을 중심으로 노화 및 노화 관련 기능 저하의 기저에 있는 생물학적 메커니즘을 연구합니다. 이 다학제적 분야는 다음과 같은 요소들을 통합합니다. 분자생물학, genetics, pharmacology, and bioinformatics to identify interventions that extend healthspan and 수명. Research spans senolytic compounds, caloric restriction mimetics, stem cell therapies, and epigenetic reprogramming, aiming to delay or reverse physiological deterioration. The following compilation presents the latest peer-reviewed publications and patents, reflecting advances in biomarkers of aging, geroprotective agents, and translational approaches targeting fundamental aging processes.

본 자료는 노화, 텔로미어, 장수 과학, 칼로리 제한, 자가포식, 미토콘드리아 기능 장애, 후성유전학적 시계, 노화 방지제, 노화 세포 제거제, 줄기세포 치료, 산화 스트레스, DNA 복구, 단백질 항상성, 염증성 노화, mTOR 억제, 시르투인, 장수 유전자, 메트포르민, 라파마이신, 세포 재프로그래밍, 노화 관련 질환, 노화 바이오마커, 기능성 식품, 수명 연장, 건강 수명, 텔로머라제 활성화, 일주기 리듬, 당화, 신경 퇴행, 호르메시스 및 후성유전학 등 다양한 주제로 분류 및 집중적으로 발표된 전 세계 영어 논문 및 특허를 엄선하여 정리한 것입니다.

Lactiplantibacillus plantarum strain and uses thereof

Patent published on the 2026-10-15 in WO under Ref WO2026215198 by CENTRO NAC DE TECNOLOGIA Y SEGURIDAD ALIMENTARIA [ES] (Aranaz Oroz Paula [es], GonzÁlez Navarro Carlos Javier [es], Goyache Sarasa Ignacio [es], Milagro Yoldi FermÍn I [es], Rodas MÉndez Ana Lucia [es], Virto Resano Raquel [es], ValdÉs Varela Lorena [es])

Abstract: The present invention relates a new probiotic strain of the species Lactiplantibacillus plantarum deposited at the "Colección Española de Cultivos Tipo (CECT)" under the accession number CECT 30972, or a variant of said strain, to compositions, pharmaceutical compositions or food products comprising said strain, and uses thereof in the prevention and/or treatment of obesity and associated metabolic diseases, inflammation, oxidative stress and fatty liver disease. The present invention also rel[...]


Our summary: The invention describes a new probiotic strain of Lactiplantibacillus plantarum with potential health benefits. It can be used in compositions for preventing or treating obesity and related metabolic disorders. Additionally, it includes various formulations like bacterial cultures and postbiotic compositions.

Lactiplantibacillus plantarum, probiotic strain, obesity treatment, metabolic diseases

Patent

Cosmetic product for modulating the microbiome and managing oxidative stress in the oral cavity, and its use

Patent published on the 2026-10-14 in SK under Ref SK2852025U by VIVAX PHARMACEUTICALS S R O [SK] (Čiko Bronislav [sk])

Abstract: Compositions for modulating the oral microbiome and managing oral oxidative stress are described. The compositions contain resveratrol, epigallocatechin gallate (EGCG), curcumin, polyphenols, and zeolite as active ingredients. The compositions may be in the form of a gel, paste, cream, mouthwash, lozenge, or chewing gum.[...]


Our summary: This cosmetic product targets the oral microbiome and oxidative stress. It includes resveratrol, EGCG, curcumin, polyphenols, and zeolite. The formulations can be delivered as gels, pastes, creams, mouthwashes, lozenges, or chewing gums.

microbiome modulation, oxidative stress management, oral health, active ingredients

Patent

Sulfurized imidazoles in ophthalmic formulations

Patent published on the 2026-10-08 in US under Ref US20260306457 by GENEIII BIOTECH CO LTD [CN] (Wang Cai Rong [us], Ding Wei [us])

Abstract: In the embodiments, ophthalmic formulations comprise 0.001-2% (w/v) of L-Ergothioneine or derivatives of L-Ergothioneine, optionally combined with compatible toxicity agents. L-ergothioneine or derivatives of L-Ergothioneine in the ophthalmic formulation is: an active pharmaceutical ingredient (API) for treating oxidative stress-related ocular disorders; and an inactive excipient for use as a stabilizing excipient to enhance bioavailability and prolong shelf-life of co-administered APIs. L-ergot[...]


Our summary: Sulfurized imidazoles are used in ophthalmic formulations containing L-Ergothioneine. These formulations enhance bioavailability and shelf-life of active pharmaceutical ingredients. L-Ergothioneine improves corneal permeability and provides synergistic effects with neuroprotective agents.

Sulfurized imidazoles, L-Ergothioneine, ophthalmic formulations, oxidative stress

Patent

A continuous enzymatic process for producing oligosaccharides from agricultural waste and low-value biomass streams

Patent published on the 2026-10-07 in IE under Ref IE20250488 by JOHN O HALLORAN [IE] (John O' Halloran [ie])

Abstract: The present invention relates to a method for the continuous and cost-effective production of nutraceutical oligosaccharides from agricultural waste and low-value biomass streams. The method comprises pre-treating biomass to break down the fibre matrix and separate hemicellulose, followed by purification to remove impurities. The purified hemicellulose is hydrolysed in an enzymatic membrane reactor using specific hemicellulases under controlled pH and temperature. Ultrafiltration is employed to [...]


Our summary: The invention describes a continuous method for producing nutraceutical oligosaccharides from agricultural waste. It involves pre-treating biomass to separate hemicellulose, followed by enzymatic hydrolysis and purification. The process utilizes specific enzymes and ultrafiltration to enhance efficiency and recycle components.

enzymatic process, oligosaccharides, agricultural waste, hemicellulose

Patent

Shenmai formula compound preparation for treating type ii diabetes

Patent published on the 2026-09-30 in ZA under Ref ZA202600064 by NINGBO POLYTECHNIC UNIV [CN] (Liu Xingyan [cn], Liu Peng [cn], Liu Yating [cn], Du Mengling [cn], Lou Jia [cn])

Abstract: The present invention discloses a Shenmai formula compound preparation for treating Type II diabetes, belonging to the field of biomedicine. The invention uses red ginseng, Ophiopogon japonicus, Bletilla striata, Leonurus japonicus, Myrrh, Saposhnikovia divaricata, and Codonopsis pilosula as raw materials for the pharmaceutical composition. Through soaking, decocting, and filtering, a Shenmai formula compound preparation for treating Type II diabetes is prepared. Experimental results show that a[...]


Our summary: The Shenmai formula compound preparation is designed to treat Type II diabetes using various herbal ingredients. Experimental results indicate significant reductions in fasting blood glucose levels in hyperglycemic model mice. This preparation shows comparable efficacy to metformin and presents a promising option for diabetes treatment.

Shenmai formula, Type II diabetes, biomedicine, hypoglycemic efficacy

Patent

Vaporization device for use in the administration by inhalation of a liquid comprising at least one active ingredient

Patent published on the 2026-09-30 in EP under Ref EP4813426 by GERVASONI CRISTINA [IT] (Gervasoni Cristina [it])

Abstract: [0001] A device (1;20) for the vaporization and the administration by inhalation of a liquid is described, the device comprising: - a tank containing a liquid to be vaporized, said liquid comprising at least one therapeutic, nutraceutical, food-supplement, phytotherapeutic, aromatherapeutic, cosmetic or general-wellness active ingredient or said liquid being a liquid classified as a medical device, - a vaporization unit comprising a heating element or an ultrasonic transducer to vaporize said li[...]


Our summary: The device is designed for vaporizing and administering liquids containing active ingredients through inhalation. It features a tank, a vaporization unit with a heating element or ultrasonic transducer, and a mouthpiece. The command-and-control unit regulates the temperature or power of the vaporization process.

vaporization, inhalation, active ingredient, device

Patent

From history to emerging frontiers

Published on 2026-09-15 by @MIT

Abstract: AbstractDiffusion MRI transformed brain imaging by making MRI sensitive not only to anatomy and spin-relaxation contrast, but also to micrometer-scale water displacements over diffusion times of a few tens of milliseconds. The resulting signal is exquisitely sensitive to tissue organization, because cell membranes, myelin, axonal packing, orientation dispersion, exchange, as well as perfusion-related incoherent fluid motion all modulate the displacement distribution sampled by diffusing water mo[...]


Our summary: Diffusion MRI revolutionized brain imaging by enabling detection of acute ischemia before conventional imaging. It allows for the exploration of white matter anisotropy through diffusion tensor imaging, aiding in understanding psychiatric disorders. Advances in technology have expanded its applications to brain development, neurodegeneration, and neurosurgery, emphasizing the importance of model assumptions in interpretation.

Diffusion MRI, tissue microstructure, diffusion tensor imaging, brain imaging

Publication

Acetylcholinesterase Inhibition Reverses Age-Related Pulmonary Decline and Increases Bronchus-Associated Lymphoid Tissue Formation in Aged Mice

Published on 2026-02-03 by Kyle Kenny, Ingrid R. Niesman, Kee S. Moon, Mark Sussman, Morgan K. Wright, Dylan Dawood, Joy A. Phillips @MDPI

Abstract: Age-related chronic, low-grade inflammation, known as inflammaging, contributes to tissue damage and disease. In the lungs, inflammaging leads to abnormal tissue remodeling, reduced function, and decreased immunity. A key factor in inflammaging is declining acetylcholine signaling, which normally suppresses inflammation and promotes tissue repair. We tested whether increasing acetylcholine responsiveness could reverse age-related lung damage. Aged mice were treated with donepezil to increase ace[...]


Our summary: Inhibition of acetylcholinesterase with donepezil reverses age-related lung damage in mice. Treatment improves blood oxygen saturation and voluntary activity while restoring alveolar structure. Increased bronchus-associated lymphoid tissue formation enhances respiratory immunity against infections.

Acetylcholinesterase, Inflammaging, Bronchus-Associated Lymphoid Tissue, Aging

Publication

다룬 주제: 장수 과학, 건강 수명, 수명, 생물학적 메커니즘, 세포 노화, 텔로미어 역학, 후성유전적 변화, 미토콘드리아 기능, 전신 염증, 분자 생물학, 유전학, 약리학, 생물정보학, 노화 세포 제거 화합물, 칼로리 제한 모방제, 줄기세포 치료, 후성유전적 재프로그래밍, 노화 바이오마커, 노화 방지제, ISO 22118, ISO 22120, ISO 22000, ISO 9001 및 ISO 14001.

역사적 맥락

1965
1970
1980
1980
1990
1960
1969
1976-05-28
1980
1990

(날짜를 알 수 없거나 관련이 없는 경우, 예를 들어 "유체역학"의 경우, 주목할 만한 등장 시기를 대략적으로 추정하여 제공합니다.)

10년차 기념일

고화질 이미지 및 다운로드는 등록된 회원에게만 100% 무료로 제공됩니다.

> 로그인 <